4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000013
President and CEO sold 4,800 shares at $28.44 ($136,512)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-05 | Sale : show line 1 in the form | −4,800 | $28.44 | $136,512 | 2,223,664 | I |
| Open-market sales · 4,800 sh · avg $28.44 · $136,512 | ||||||
Loading xslF345X03/wf-form4_167331845186326.xml…